InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Flynn Karen, Président des Biologiques et CCO. Insider active across 5 companies, notably Catalent, Inc.. Aggregated, 18 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €254k. History available since 26 July 2021. The latest transaction was filed on 22 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Flynn Karen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
4,975 股Ordinary SharesSEC:0001193125-26-283788:0
1,493 股Ordinary SharesSEC:0001193125-26-283788:1
14,970 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242231:0
23,372 股0Common StockSEC:0001553599-26-000001:0
19,132 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-25-077814:0
7,435 股0Common StockSEC:0001562180-25-000202:0
20,089 股0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-24-066037:0
2,947 股0Common StockSEC:0001562180-24-000232:0
6,993 股0Common StockSEC:0001596783-23-000153:0
8,083 股0Common StockSEC:0001562180-23-000102:0
4,149 股0Common StockSEC:0001596783-22-000169:0
1,066 股@ US$10.4881.2% 占其流量Common StockSEC:0001562180-22-007044:0
245 股0Common StockSEC:0001596783-22-000142:0
164 股@ US$16.7918.8% 占其流量Common StockSEC:0001562180-22-005558:0
13,227 股0Common StockSEC:0001562180-22-005091:0
2,472 股@ US$116.64100.0% 占其流量Common StockSEC:0001596783-22-000014:0
1,151 股0Common StockSEC:0001596783-21-000092:0
10.75 股Common StockSEC:0001225208-16-023358:0
18 条申报中的 18 条
About Flynn Karen
Flynn Karen is Président des Biologiques et CCO. She has 18 filings in total, and in the 18 sampled filings the activity runs from 2016-01-05 to 2026-06-26, with EUR 0 of buys and EUR 253950 of sells; the main filings concern Catalent, Inc., Quanterix Corp, Stevanato Group S.p.A. and Sotera Health Co.
